New Immunogenicity Analysis Tool Emerges From URI-Dartmouth-EpiVax Collaboration
Tuesday, July 8, 2014 - 13:30
in Health & Medicine
A partnership born out of the URI Institute for Immunology and Informatics has resulted in a new web-based tool designed to help manufacturers of protein-based therapeutics improve the safety of their manufacturing processes, avoiding problems that caused the U.S. Food and Drug Administration to suspend a clinical trial in 2012.